Literature DB >> 3408742

Numerous proteins phosphorylated on tyrosine and enhanced tyrosine kinase activities in vanadate-treated NIH 3T3 fibroblasts.

J K Klarlund1, S Latini, J Forchhammer.   

Abstract

A monoclonal antibody that can immunoprecipitate proteins containing phosphotyrosine has been isolated and characterized. To identify proteins that can act as substrates for tyrosine kinases in intact cells, extracts of phosphate-labeled NIH cells that had been treated with the phosphotyrosyl phosphatase inhibitor, vanadate, were precipitated with the antibody, and the immunoprecipitates were analyzed by two-dimensional gel electrophoresis. Numerous proteins were specifically precipitated from vanadate-treated NIH 3T3 cells by the antibody. The high level of phosphotyrosine detected in vanadate-treated cells is presumably primarily due to phosphatase inhibition, but approx. 2-fold increased tyrosine kinase activities were also detected in extracts of the cells after treatment with vanadate. The enhanced tyrosine kinase activity may contribute to the generation of the transformed phenotype seen in response to treatment with vanadate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3408742     DOI: 10.1016/0167-4889(88)90167-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Unique and selective mitogenic effects of vanadate on SV40-transformed cells.

Authors:  H Wang; R E Scott
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

2.  Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms.

Authors:  J K Olson; G A Bishop; C Grose
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  A mitogen-responsive promoter region that is synergistically activated through multiple signalling pathways.

Authors:  Q Ouyang; M Bommakanti; W K Miskimins
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

4.  Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients.

Authors:  Michael E Brier; Jessica R Gooding; James M Harrington; Jason P Burgess; Susan L McRitchie; Xiaolan Zhang; Brad H Rovin; Jon B Klein; Jonathan Himmelfarb; Susan J Sumner; Michael L Merchant
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.